CAR-T cell therapy for cancer causes 'brain fog,' study shows

How CAR-T cancer therapies could harm the brain

Immune-system responses to cell therapies produce long-term effects on cognition in mice. Immune-system responses to cell therapies produce long-term effects on cognition in mice.

New Zealand promotes expensive cancer therapy while at the same time promoting one of the causes of cancer

New Zealand’s Stuff newspaper has been publishing a series of articles about using CAR T-cell therapy to treat lymphatic cancers.  New Zealand has the highest rate of lymphoma in the world.  In […] The post New Zealand promotes expensive cancer therapy while at the same time promoting one of the causes of cancer first appeared on The Expose.

CAR T-Cell Therapy for Relapsed/Refractory Follicular Lymphoma

(MedPage Today) -- When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates, and lengthy survival outcomes...

Survey shows majority of Americans unaware of innovative cancer treatment

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy. The little known, but highly promising technology breakthrough makes it possible for your body to fight cancer, often without invasive surgery, offering patients new hope for the possibility of long-term remission.  However, a new survey by Roswell Park Comprehensive Cancer Center of 1,021 adults in the U…

CAR-T cell therapy for cancer causes 'brain fog,' study shows

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

Promising results after CAR T-cell therapy for leukemia and lymphoma

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in previous studies. This is shown in a new compilation of Swedish treatment results conducted by researchers in the SWECARNET network.